The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Short-term Pulmonary Vasodilation With l-Arginine in Pulmonary Hypertension
Abstract
Background Endothelial dysfunction may contribute to the pathogenesis of pulmonary hypertension through impaired production of the endothelium-derived vasodilator nitric oxide (NO).l-Arginine, the substrate for NO synthase (NOS), has a vasodilatory effect in systemic vascular beds and can correct abnormal endothelium-dependent vasodilation. It has been suggested that these two effects of l-arginine are mediated through NOS metabolism and enhanced NO production. Therefore, we assessed the short-term pulmonary hemodynamic effects of exogenous l-arginine in patients with pulmonary hypertension of various origins. Methods and Results During continuous hemodynamic monitoring, 10 subjects with pulmonary hypertension (mean pulmonary artery pressure [PAP], 54±5 mm Hg [mean±SEM]) received a 30-minute control infusion of hypertonic saline followed by a 30-minute infusion of 500 mg/kg of l-arginine. The hemodynamic effects of l-arginine were compared with those of prostacyclin titrated to maximally tolerated doses. The hemodynamic response to l-arginine was also studied in 5 subjects with heart failure but without pulmonary hypertension (mean PAP, 20±2 mm Hg) and 5 healthy control subjects. In subjects with pulmonary hypertension, infusion of l-arginine reduced mean PAP by 15.8±3.6% (P<.005) and pulmonary vascular resistance (PVR) by 27.6±5.8% (P<.005) compared with decreases of 13.0±5.5% (P<.005) and 46.6±6.2% (P<.005), respectively, with prostacyclin.l-Arginine infusion also increased the mean plasma level of l-arginine from 59±6 μmol/L to 10 726±868 μmol/L (P<.005), which was associated with a significant increase in the plasma level of l-citrulline, the immediate product of NOS metabolism of l-arginine. Moreover, the peak plasma level of l-citrulline correlated significantly with the reductions in mean PAP (r=.71,P<.05) and PVR (r=.70,P<.05), consistent with vasodilation mediated by NOS metabolism of exogenous l-arginine and increased NO production.l-Arginine also had a modest hypotensive effect in healthy control subjects and reduced systemic vascular resistance in subjects with heart failure in the absence of pulmonary hypertension. However, only small reductions in absolute pulmonary vascular resistance were observed in this latter group in response to l-arginine that did not reach significance. Conclusions An exaggerated short-term pulmonary vasodilatory response to l-arginine in patients with pulmonary hypertension suggests a relative impairment in pulmonary vascular endothelial NO production that may contribute to increased pulmonary vascular tone and thus be important in the pathophysiology of pulmonary hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
PEPKEZABA, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)92033-x · Cited by 1,055
Cited by
Medical Therapy For Pulmonary Arterial Hypertension
Badesch, D. B., Abman, S. H., Ahearn, G. S., Barst, R. J., McCrory, D. C., Simonneau, G., & McLaughlin, V. V. (2004) · Chest · doi:10.1378/chest.126.1_suppl.35s · Cited by 829
Morris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 763
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Primary pulmonary hypertension
Runo, J. R., & Loyd, J. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13167-4 · Cited by 521
Pulmonary Hypertension Due to Left Heart Disease
Guazzi, M., & Borlaug, B. A. (2012) · Circulation · doi:10.1161/circulationaha.111.085761 · Cited by 483
Metadata
- Authors
- Mehta, S., Stewart, D. J., Langleben, D., & Levy, R. D.
- Venue
- Circulation
- Published
- 1995-09-15
- Volume
- 92
- Issue
- 6
- Pages
- 1539-1545
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1975961217
- Cited by
- 177
- References
- 1
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Short-term Pulmonary Vasodilation With l-Arginine in Pulmonary Hypertension. https://app.cochat.ai/papers/10.1161/01.cir.92.6.1539
- The paper
- Mehta, S., Stewart, D. J., Langleben, D., & Levy, R. D. (1995). Short-term Pulmonary Vasodilation With l-Arginine in Pulmonary Hypertension. Circulation. https://doi.org/10.1161/01.cir.92.6.1539
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.